Inventor
Hans Fliri
Inventor
Essex, GB
Overview
Patents· 22 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds30%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds10%
C07KPeptides10%
Y02PClimate change mitigation technologies in the production or processing of goods7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
G01NInvestigating or analysing materials by determining their chemical or physical properties2%
PatentTitleYear
9,895,412'Cyclic depsipeptide compounds and their uses'20189,670,216'Cannabinoid-2 agonists'20179,670,175'Protected succinates for enhancing mitochondrial ATP-production'20179,382,295'Cyclic depsipeptide compounds and their uses'20169,062,004'Cannabinoid-2 agonists'20158,933,015'Macrocyclic inhibitors of flaviviridae viruses'20158,513,184'Macrocyclic inhibitors of flaviviridae viruses'20138,420,637'Abnormal cannabidiols as agents for lowering intraocular pressure'20137,968,711'Abnormal cannabidiols as agents for lowering intraocular pressure'20117,868,032'Prostamide receptor antagonists'20117,718,830'Abnormal cannabidiols as agents for lowering intraocular pressure'20107,718,767'3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection'20107,618,966'Abnormal Cannabidiols as agents for lowering intraocular pressure'20097,612,101'Abnormal cannabidiols as agents for lowering intraocular pressure'20097,196,161'3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis C infection'20074,855,421'2-Oxoazetidines, methods for their preparation, and their use'19894,720,491'Fluoralkylatedcarbapenem derivatives'19884,720,490'Fluoralkylatedcarbapenem derivatives'19884,503,221'Process for cephalosporanic acid derivatives and intermediate therefor'19854,477,448'Cephalosporin derivatives and use as antimicrobial agents'19844,440,767'Derivatives of cephalosporanic acid, processes for their production and their use'19844,320,133'Penicillins and their antibacterial use'1982Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1982–1988Patents assigned to SANDOZ LTD (5)· patent assignee history
1982–1989Based in Vienna, AT· patent location history
2009–2017Patents assigned to ALLERGAN INC (8)· patent assignee history
2009–2015Based in Essex, GB· patent location history
2011Based in Saffron Walden, GB· patent location history
2013–2015Patents assigned to CHEN JUNE (2)· patent assignee history
2013–2015Patents assigned to FLIRI HANS (2)· patent assignee history
2015–2017Based in Saffron Waldon, GB· patent location history
2016–2018Patents assigned to CYPRALIS LTD (2)· patent assignee history
2016–2018Based in Ongar, GB· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ALLERGAN INC | 8 | 2009–2017 |
| SANDOZ LTD | 5 | 1982–1988 |
| CHEN JUNE | 2 | 2013–2015 |
| CYPRALIS LTD | 2 | 2016–2018 |
| FLIRI HANSself | 2 | 2013–2015 |
Locations
| Location | Patents | Span |
|---|---|---|
| Essex, GB | 6 | 2009–2015 |
| Vienna, AT | 6 | 1982–1989 |
| Ongar, GB | 3 | 2016–2018 |
| Saffron Waldon, GB | 2 | 2015–2017 |
| Saffron Walden, GB | 2 | 2011 |